Affiliations: Theregen Inc., San Francisco, CA, USA. E-mail:
[email protected]
Abstract: Anginera™ is a bioresorbable
scaffold-based, three dimensional human dermal fibroblast culture developed for
the treatment of diffuse small vessel disease in human hearts.
Keywords: Anginera™, fibroblast, small vessel disease